Article

Soy isoflavone supplementation for breast cancer risk reduction: a randomized phase II trial.

Department of Surgery, Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago IL 60611, USA.
Cancer Prevention Research (Impact Factor: 4.89). 02/2012; 5(2):309-19. DOI: 10.1158/1940-6207.CAPR-11-0251
Source: PubMed

ABSTRACT Soy isoflavone consumption may protect against breast cancer development. We conducted a phase IIB trial of soy isoflavone supplementation to examine its effect on breast epithelial proliferation and other biomarkers in the healthy high-risk breast. One hundred and twenty-six consented women underwent a random fine-needle aspiration (rFNA); those with 4,000 or more epithelial cells were randomized to a double-blind 6-month intervention of mixed soy isoflavones (PTIG-2535) or placebo, followed by repeat rFNA. Cells were examined for Ki-67 labeling index and atypia. Expression of 28 genes related to proliferation, apoptosis, and estrogenic effect was measured using quantitative reverse transcriptase PCR. Hormone and protein levels were measured in nipple aspirate fluid (NAF). All statistical tests were two-sided. Ninety-eight women were evaluable for Ki-67 labeling index. In 49 treated women, the median Ki-67 labeling index was 1.18 at entry and 1.12 post intervention, whereas in 49 placebo subjects, it was 0.97 and 0.92 (P for between-group change: 0.32). Menopausal stratification yielded similar results between groups, but within premenopausal soy-treated women, Ki-67 labeling index increased from 1.71 to 2.18 (P = 0.04). We saw no treatment effect on cytologic atypia or NAF parameters. There were significant increases in the expression of 14 of 28 genes within the soy, but not the control group, without significant between-group differences. Plasma genistein values showed excellent compliance. A 6-month intervention of mixed soy isoflavones in healthy, high-risk adult Western women did not reduce breast epithelial proliferation, suggesting a lack of efficacy for breast cancer prevention and a possible adverse effect in premenopausal women.

0 Bookmarks
 · 
147 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The societies of the world in the 21(st) century have faced challenges arising from an aging population as the fertility rate has dropped dramatically and medical advances have extended the average human life span. The elderly aged 65 years or older make up at least 20% of the population in Korea, making the country a super-aging society as defined by the United Nations. The number of elderly women is higher than that of elderly men and women live longer than men. Based on the analysis of recent trends in previous studies, this study aimed to suggest practical strategies to utilize isoflavones, substances chemically similar to the female hormone estrogen, and to search for effective anti-aging strategies using this substance for women to be prepared to reach the elderly stage in good health.
    Journal of menopausal medicine. 12/2014; 20(3):85-9.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Background and aim of the work: Antioxidants can reduce damage produced by low doses of radiation on living cells. This study was designed to investigate the effects of fermented soy milk (FSM) and low dose of gamma radiation on carcinogenic effect of N-methyl-N-nitrosourea (MNU). Material and methods: Female rats were divided into 8 groups: group (1): control, group (2): injected with MNU, group (3): whole body exposed to low dose of gamma radiation (0.5 Gy), group (4): given FSM orally, group(5): given FSM and MNU, group (6): received MNU and exposed to gamma radiation,, group (7): given FSM, MNU and exposed to gamma radiation. Results: Fermented soy milk exerted significant, ameliorative effect on glutathione peroxidase, superoxide dismutase and catalase activities, lipid peroxidation and TNF-α levelin rats injected with MNU. Combined treatment of FSM and low dose of gamma radiation markedly elevated GSH level, ameliorated MNU effect on cell cycle phases Go/1, S, G2/M and induce apoptosis via activation of caspase-3.Conclusion: FSM consumption with exposure to low doses of gamma radiation reduced carcinogenesis and oxidative stress effects induced by MNU in the mammary tissues.
    Nature and Science of Sleep 01/2013; 11(11):35-42.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Ribonuclease P (RNase P) is an essential endonuclease that catalyzes the 5' end maturation of precursor tRNA (pre-tRNA). Bacterial RNase P is an attractive potential antibacterial target because it is essential for cell survival and has a distinct subunit composition compared to the eukaryal counterparts. To accelerate both structure-function studies and discovery of inhibitors of RNase P, we developed the first real-time RNase P activity assay using fluorescence polarization/anisotropy (FP/FA) with a 5' end fluorescein-labeled pre-tRNA(Asp) substrate. This FP/FA assay also detects binding of small molecules to pre-tRNA. Neomycin B and kanamycin B bind to pre-tRNA(Asp) with a Kd value that is comparable to their IC50 value for inhibition of RNase P, suggesting that binding of these antibiotics to the pre-tRNA substrate contributes to the inhibitory activity. This assay was optimized for high-throughput screening (HTS) to identify specific inhibitors of RNase P from a 2880 compound library. A natural product derivative, iriginol hexaacetate, was identified as a new inhibitor of Bacillus subtilis RNase P. The FP/FA methodology and inhibitors reported here will further our understanding of RNase P molecular recognition and facilitate discovery of antibacterial compounds that target RNase P.
    Nucleic Acids Research 09/2014; · 8.81 Impact Factor

Full-text (2 Sources)

Download
57 Downloads
Available from
May 19, 2014